Gastro Broadcast Gastro Broadcast

For Esophageal Cancer Awareness Month, Dr. Naresh Gunaratnam speaks with Dr. Srinadh Komanduri, associate chief of gastroenterology and hepatology and director of endoscopy at Northwestern Medicine, about efforts to educate the public about esophageal cancer and cutting-edge tools that are helping gastroenterologists determine which of their patients are at greatest risk of developing esophageal cancer.

Esophageal cancer is preventable if high-risk patients, such as those with Barrett's Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett’s tissue.

Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate.

The Barrett's Esophagus surveillance program at Northwestern includes the TissueCypher test, which provides Dr. Komanduri and his colleagues with a personalized prediction of cancer progression risk based on molecular biomarkers that cannot be measured by traditional pathology.

Join Dr. Gunaratnam and Dr. Komanduri to hear how gastroenterologists and pathologists can better identify patients who are most at-risk and provide the appropriate care to help prevent them from developing esophageal cancer.

--

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 56

Kevin Harlen interviews Robert Raleigh, chief operating officer and general counsel for Sebela Pharmaceuticals, which has been innovating in the area of colonoscopy prep since the 1980’s.

Achieving adequate bowel preparation is challenging but critical to achieve a good-quality colonoscopy. But many studies have shown that a majority of patients have reported the preparation is the most difficult part of screening.

Join Kevin and Rob as they discuss how Sebela is working on improving access to low-volume preparations and advocating for policies to remove barriers to effective colorectal cancer screening.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 55

Dr. Michael Weinstein interviews Dr. Prashant Krishnan and Dr. Neil Sharma of Peak Gastroenterology Associates in Colorado about building an interventional gastroenterology practice.

Peak Gastroenterology is working to deliver interventional endoscopy and endoscopic oncology care to its community, which has historically only been available in larger health systems and academic settings.

Join Dr. Weinstein, Dr. Krishnan, and Dr. Sharma as they explore some of the barriers to highly specialized medical care in private practice and the potential opportunities to overcome those barriers.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 54

Host Kevin Harlen interviews Sap Sinha, chief operating officer of Allied Digestive Health where he leads its management service organization.

Allied Digestive Health has multiple locations in New Jersey and New York, with 160 gastroenterologists and more than 200 clinicians. The organization recently partnered with Provation, so that physicians and nurses across its various offices will be able to document patient visits and procedures across any internet-enabled device.

Another recent partnership with Lynx.MD, a medical data intelligence platform enables the integrated practices to develop, test and validate GI-related treatments and therapies.

Join Kevin and Sap to hear about how these technology platforms are enabling Allied Digestive Health to enhance operations in its practices and how innovations in technology and data can help improve patient care.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 53

Dr. Lisa Mathew interviews Dr. Russ Arjal, who is the co-founder, chief medical officer, and president of Telebelly, a virtual GI clinic offering remote care to patients.

Telebelly provides nurse practitioners, physician assistants, and medical assistants to support GI practices and their patients.

Join Dr. Mathews and Dr. Arjal as they explore the future of independent GI and the innovations that will help practices compete and thrive in the future.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Mixed and mastered by Hayden Margolis

Gastro Broadcast, Episode 52

Dr. Michael Weinstein interviews Dr. Andreas Muehler, chief medical officer of Immunic Therapeutics, which is developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.

At United European Gastroenterology Week, Immunic presented data from the company’s phase 1b clinical trial of IMU-856, an orally available and systemically acting small molecule modulator used to treat celiac disease. Immunic’s new approach to treatment entails restoring a healthy gut wall by modulating SIRT6, a stress responsive protein that helps repair our cells.

Join Dr. Weinstein and Dr. Muehler as they explore the challenges faced by patients with celiac disease and new innovations that will impact the way physicians treat their patients.

Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC

Original score by Hayden Margolis

Gastro Broadcast, Episode 51